Now Playing: Video, Audio and Print Programs Produced by Dr Neil Love

RTP On Demand: Current and Future Role of PARP Inhibitors in the Management of Ovarian Cancer (Audio Program)

Featuring interviews with Drs Ursula A Matulonis, Thomas J Herzog and Michael Birrer. (Audio Content)

Go to Current Issue | Browse Past Issues

Browse by Tumor Type

About Us

Led by medical oncologist Dr Neil Love, Research To Practice produces medical education activities geared toward physicians, nurses and other allied healthcare providers. Programs feature audio interviews, case-based discussions, Patterns of Care studies, web video and patient perspectives projects.

Subscribe to RTP Programs
If you are a physician, nurse or other allied healthcare professional and are interested in receiving our complimentary programs, please click here.

Regional Meetings

Upcoming Events

April 3, 2017 | Molecular Tumor Board | Washington, DC

Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment

May 3 – May 5, 2017 | Oncology Grand Rounds | Denver, CO

Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice — A CNE Symposia Series Held During the 42nd Annual ONS Congress

June 2, 2017 | NSCLC CME Symposium | Chicago, IL

Point-Counterpoint: Investigators Discuss and Debate Clinical Questions and Controversies in Non-Small Cell Lung Cancer

Grand Rounds Non-Small Cell Lung Cancer Regional Series

Beyond the Guidelines: Clinical Investigators Provide Perspectives on Biomarker-Guided Decision-Making for Patients with Non-Small Cell Lung Cancer

Grand Rounds Gastrointestinal Cancer Regional Series

Recently Approved and Emerging Strategies in the Management of Gastrointestinal Cancers: An Interactive Grand Rounds Series

Grand Rounds Ovarian Cancer Regional Series

Second Opinion: Clinical Investigators Provide Their Perspectives on Clinical Questions and Controversies in the Diagnosis and Treatment of Ovarian Cancer